Next Article in Journal
Comparison of Extended Skin Cancer Screening Using a Three-Step Advanced Imaging Programme vs. Standard-of-Care Examination in a High-Risk Melanoma Patient Cohort
Next Article in Special Issue
Current Applications and Future Directions of Circulating Tumor Cells in Colorectal Cancer Recurrence
Previous Article in Journal
Immune Microenvironment in Childhood Cancers: Characteristics and Therapeutic Challenges
Previous Article in Special Issue
Prospective, Observational Study of Aflibercept Use in Combination with FOLFIRI in Patients with Metastatic Colorectal Cancer: A Real-World Effectiveness Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 16
Issue 12
10.3390/cancers16122203
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction published on 6 November 2024, see Cancers 2024, 16(22), 3745.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Comparative Study of Postoperative Complications Associated with Distal Gastrectomy and Pylorus-Preserving Gastrectomy among Gastric Cancer Patients Based on Nationwide Survey Data and Propensity Score Weighting

by
Sang-Ho Jeong
1,†,
Miyeong Park
2,†,
Kyung Won Seo
3,
Rock Bum Kim
4,
Jae-Seok Min
5,* and
Information Committee of the Korean Gastric Cancer Association
1
Department of Surgery, Gyeongsang National University College of Medicine, Gyeongsang National University Changwon Hospital, Changwon 51472, Republic of Korea
2
Department of Anesthesiology, Gyeongsang National University Changwon Hospital, Changwon 51472, Republic of Korea
3
Department of Surgery, Kosin University Gospel Hospital, Busan 49267, Republic of Korea
4
Regional Cardiocerebrovascular Disease Center, Gyeongsang National University Hospital, Jinju 52727, Republic of Korea
5
Department of Surgery, Korea University College of Medicine, and Division of Foregut Surgery, Korea University Anam Hospital, Seoul 02841, Republic of Korea
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cancers 2024, 16(12), 2203; https://doi.org/10.3390/cancers16122203
Submission received: 24 April 2024 / Revised: 9 June 2024 / Accepted: 10 June 2024 / Published: 12 June 2024 / Corrected: 6 November 2024
(This article belongs to the Special Issue Developments in the Management of Gastrointestinal Malignancies)
Browse Figures
Versions Notes

Abstract

:

Simple Summary

This study compared postoperative complication rates between pylorus-preserving gastrectomy (PPG) and distal gastrectomy (DG) using Korean nationwide survey data with propensity score weighting (PSW). PPG preserves gastric function but may lead to more complications than DG. Before PSW, 87.8% of DG and 87.1% of PPG patients had no complications (p = 0.053). Severe complications were more frequent in PPG (6.6%) than in DG (3.8%) (p = 0.039). After PSW, overall and severe complication rates were similar (p = 0.960 and p = 0.574). Anastomotic stricture and leakage rates were higher in PPG (2.9% and 1.7%) than in DG (0.6% and 0.5%) before PSW, but not after (p = 0.999 and 0.123). The PSW-adjusted analysis indicates no significant difference in complication rates between PPG and DG.

Abstract

Background/Objective. This study aimed to compare complication rates between pylorus-preserving gastrectomy (PPG) and distal gastrectomy (DG) using Korean nationwide survey data and propensity score weighting (PSW). PPG preserves gastric function but may lead to more postoperative complications than DG. Methods and Results. We analyzed 9424 gastric cancer patients who underwent either DG (n = 9183) or PPG (n = 241). PSW balanced variables such as age, sex, TNM stage, comorbidities, ASA score, and surgical approach. Before PSW, 87.8% of DG patients and 87.1% of PPG patients had no complications (p = 0.053). Severe complications (Clavien–Dindo IIIa or higher) were more frequent in PPG (6.6%) than in DG (3.8%) (p = 0.039). After PSW, overall complication rates (p = 0.960) and severe complication rates (p = 0.574) were similar between groups. Incidence rates of anastomotic stricture and leakage were higher in PPG (2.9% and 1.7%) compared to DG (0.6% and 0.5%) (p = 0.001 and 0.036) before PSW, but these differences were not significant after PSW (p = 0.999 and 0.123). Conclusion. The PSW-adjusted analysis indicates no significant difference in overall and severe complication rates between PPG and DG in gastric cancer patients.

1. Introduction

Function-preserving gastrectomy has emerged due to its beneficial postoperative outcomes. Various approaches have been used to perform function-preserving gastrectomy up to the location of the gastric tumor in cases of early gastric cancer (EGC). These techniques can be employed to minimize the extent of gastric resection and improve postoperative functionality without compromising the recurrence rate after surgery [1,2,3,4,5,6,7]. These function-preserving gastrectomy methods include pylorus-preserving gastrectomy (PPG), proximal gastrectomy (PG), vagus nerve-preserving gastrectomy, and sentinel node navigation with stomach-preserving surgery. Among these methods, PPG can be used to resect EGC tumors commonly located in the middle third of the stomach.
PPG was first used to treat peptic ulcers and was later used to treat gastric cancer in Eastern Asia countries Japan and Korea [5,8,9,10]. While some retrospective studies or meta-analyses have highlighted the functional advantages of PPG compared with conventional distal gastrectomy (DG) for EGC, high-quality multicenter randomized controlled trials have yet to be performed, and, therefore, there is no solid evidence regarding the superiority of PPG. Nevertheless, PPG offers several benefits compared to conventional DG, including lower incidence rates of bile reflux, dumping syndrome, and gallstones. Furthermore, PPG offers superior nutritional advantages resulting in minor changes in body weight [8,11,12,13,14,15,16,17].
However, PPG has several disadvantages; therefore, it is not widely used to treat EGC. After PPG, delayed gastric emptying can occur because the remaining pylorus does not function initially, thus leading to complications such as gastric acid reflux [8,18,19,20]. Compared to conventional DG, PPG requires sophisticated surgical techniques to save the pylorus [8,21,22,23,24]. During surgery, accurate localization of the gastric tumor is sometimes difficult [8,25]. When performing lymph node dissection during PPG, additional care is needed, such as saving the right gastric artery and first branch of the gastroepiploic artery [8,21]. However, despite such efforts, the incidence of postoperative complications in the PPG group was not significantly lower than that in the DG group, which is an obstacle to the widespread application of PPG. Selection bias may have affected the results of previous retrospective studies comparing DG and PPG because PPG was mostly performed at the same institution or at a single institution [15,26,27]. In contrast, the present study compared the occurrence of complications between DG and PPG based on data from the 2019 Korean Gastric Cancer Association (KGCA)-led nationwide survey targeting a large number of institutions [28]. Additionally, in this nationwide survey study, propensity score weighting (PSW) was implemented to reduce bias and minimize the difference between the DG and PPG groups.

2. Materials and Methods

2.1. Collection of Survey Data

The 2019 nationwide survey conducted by the Information Committee of the KGCA utilized a case report form (CRF) [28,29]. The CRF comprised 54 questions and was sent to each institution participating in this nationwide survey. The role of the Information Committee of the KGCA was to review and filter any incorrect or missing data, with representatives from each institution being consulted for clarification. The data collection period spanned from March to December 2020, during which patient demographic data, medical history, pathological findings, operative methods, and surgical outcomes were collected via email [28]. The histological data were categorized according to the 2010 World Health Organization classification, while pathological staging followed the eighth edition of the American Joint Committee on Cancer tumor–node–metastasis (TNM) classification [30,31]. This multicenter, retrospective, observational study included 14,076 patients from 68 institutions. Furthermore, the need for informed consent was waived. Approval for the study was obtained from the Institutional Review Board (IRB) at Gyeongsang National University Hospital in Changwon (IRB No. GNUCH-2023-09-024).
We included a total of 13,088 patients who underwent curative radical gastrectomy (R0). To analyze complication rates, we excluded cases with missing complication values, leaving us with 12,244 patients diagnosed with stages 1 to 3 gastric cancer and with Clavien–Dindo (CD) classification complication records [32]. Within this group, we further excluded patients who underwent total gastrectomy (TG) (n = 2445), PG (n = 332), wedge resection (WR) (n = 32), or had missing values (n = 11), ultimately resulting in a sample of 9424 patients who underwent either conventional DG (n = 9183) or PPG (n = 241). PSW was conducted to compare data between the DG (n = 239.7) and PPG (n = 241) groups (Figure 1). The reasons why some surgeons prefer PPG to conventional DG are several benefits such as lower incidences of dumping syndrome, bile reflux, and gallstones after gastrectomy.
Postoperative complications were events that occurred within 30 days after surgery for gastric cancer, including anastomotic site problems (e.g., stricture or leakage), duodenal stump leakage, intra-abdominal fluid retention or abscess, hemorrhage in the intra-abdominal or intraluminal area, mechanical ileus, wound complications, pancreatic fistula, heart disease, cerebrovascular events, and pneumonia [28]. These complications were categorized using the CD classification. Severe complications were defined as those included in the CD IIIa or higher subgroup. Postoperative death was defined as death within 30 days after gastrectomy or during hospitalization [28].

2.2. Statistical Analysis

Categorical variables are presented as frequency (proportion) values and were compared by chi-square tests to test for differences between groups.
Continuous variables are presented as the mean ± standard deviation (SD) or as medians and interquartile ranges (IQRs).
Differences in continuous variables were evaluated using independent sample t tests with non-PSW data and weighted independent sample t tests with PSW data.
It was necessary to compare the two groups (DG and PPG) with regard to potential confounding variables because there were differences in the confounding variables between the two groups.
This was accomplished using propensity score weighting. The variables used to compute the weight based on the propensity score were age, sex, TNM stage, comorbidities, ASA score, and approach method, all of which differed between the DG and PPG groups.
After conducting PSW, the balance of variables between the two groups was assessed by plotting the love plot, which presents unweighted and weighted standardized mean differences of variables.
Odds ratios (ORs) for severe complications (CD IIIa or higher) were assessed from logistic regression models for non-PSW data and weighted logistic regression models for PSW data.
After multivariate logistic analysis and PSW were performed, the covariates were selected based on clinical considerations and confounders known from risk stratification models.
All p values (2 tailed) < 0.05 were considered to indicate statistical significance.
Statistical analysis was performed using the statistical software R 4.3.0 (R Core Team (2021), R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/, accessed on 1 February 2024), including the PSW packages “cobalt” and “WeightIt”.

3. Results

3.1. Comparison of Patient Demographics between the DG and PPG Groups before PSW

The demographic characteristics of the enrolled patients are shown in Table 1. Univariate analysis of the DG and PPG groups revealed that patient age, sex, body mass index, tumor size, TNM stage, presence of comorbidities, ASA score, surgical approach, severe morbidity rate, and severe complication rate were significantly different between the two groups.
The patients in the DG group (average 62.9 years) were significantly older than those in the PPG group (average 60 years) (p < 0.001). In terms of sex, the proportion of women was lower in the DG group (35.6%) than in the PPG group (53.5%) (p < 0.001). Body mass index (BMI) was greater in the DG group (average 24.1 kg/m2) than in the PPG group (average 23.6 kg/m2) (p = 0.013). The tumor size was greater in the DG group (average 3.3 cm) than in the PPG group (average 2.2 cm) (p < 0.001). TNM stage I was less common in the DG group (74%) than in the PPG group (94.2%) (p < 0.001). There was a higher rate of comorbidities in the DG group (59.5%) than in the PPG group (37.3%) (p < 0.001). The prevalence of an ASA score of 1 was lower in the DG group (23.7%) than in the PPG group (42.7%), while the prevalences of scores of 2 and 3 were higher in the DG group than in the PPG group (p < 0.001).
The two operations differed significantly in terms of the approach used (p < 0.001). Open surgery was performed in 20.3% of the patients in the DG group but in only 1.2% of the patients in the PPG group. In the case of robotic gastrectomy, DG was performed in 6.6%, and PPG was performed in 25.7%. Similarly, laparoscopic gastrectomy was performed in 73.1% of patients in the DG group (65.2% in the totally laparoscopic group and 7.9% in the laparoscopy-assisted group) and 73.0% of patients in the PPG group (47.3% in the totally laparoscopic group and 25.7% in the laparoscopy-assisted group). There was no significant difference in the number of harvested lymph nodes between the DG group (average 38.8) and the PPG group (average 40.7) (p = 0.07).
Before PSW, there was no significant difference in the percentage of patients who experienced postoperative complications (87.8% in the DG group and 87.1% in the PPG group) (p = 0.053) (Table 1). On the other hand, when comparing the rates of severe complication (CD IIIa or higher), there was a significant difference between the DG (3.8%) and PPG (6.6%) groups (p = 0.039). Even when severe complications were compared among patients who underwent minimally invasive surgery rather than open surgery, there was a significant difference between the DG (3.3%) and PPG groups (6.6%) (p = 0.017). However, among patients who underwent minimally invasive surgery, the postoperative mortality rate was not significantly different between the DG (0.2%) and PPG groups (0%) (p = 1.0).

3.2. Multivariate Analysis of Risk Factors for Severe Complications (CD IIIa or Higher) and PSW

Before conducting PSW, the incidence rates of severe complications (CD IIIa or higher) were compared between the DG and PPG groups. The complications that were significantly different between the two operations were anastomotic leakage and stricture, both of which were more common in the PPG group (p = 0.036 and 0.001) (Table 2).
After conducting PSW, multivariate logistic regression analysis was performed using severe complications (CD IIIa or higher) as the dependent variable (Table 3). Sex, disease stage, comorbidities, ASA score, and surgical approach were identified as significant risk factors for severe complications. Based on the results of multivariate analysis, the propensity score was calculated, and PSW was performed to adjust weights in the DG group. As a result, compared to the original red spot, the weighted group blue spot after PSW had standardized mean differences gathered around the value of 0, showing that there was no significant difference between the DG and PPG groups (Figure 2).

3.3. Comparison of Patients’ Demographic Data between the DG and PPG Groups after PSW

After conducting PSW, there were no significant differences in patients’ age, sex, TNM stage, presence of comorbidities, ASA score, or length of hospital stay (Table 1). Among the patients’ demographic data, BMI and tumor size were significantly different between the DG and PPG groups. The patients who underwent PPG had significantly lower BMIs and smaller tumor sizes than those who underwent DG (p = 0.006 and <0.001). The number of harvested lymph nodes was greater in the PPG group (average 40.7) than in the DG group (average 38.5) (p = 0.039).

3.4. Comparison of Postoperative Complications between the DG and PPG Groups after PSW

After conducting PSW, the rate of complications did not differ between the DG and PPG groups (p = 0.960). Additionally, the rates of severe complications (CD IIIa or higher) did not differ between the two groups (p = 0.574) (Table 1).
Even for anastomotic leakage—which showed significantly different rates before PSW—there was no significant difference between the DG (n = 0.4) and PPG groups (n = 4.0) (p = 0.123). Additionally, there was no significant difference in the incidence of anastomosis strictures between DG (n = 6.2) and PPG groups (n = 7.0) (p = 0.999) (Table 2).

4. Discussion

This study compared rates of complications between patients who underwent conventional DG and those who underwent PPG to treat gastric cancer. PSW was conducted based on nationwide survey data from the 2019 KGCA. There was a significant difference in the incidence of severe complications between the DG (3.8%) and the PPG groups (6.6%) among patients with CD IIIa or higher before conducting PSW (p = 0.039). Among the types of complications, anastomotic leakage and stricture were found to be significantly more common after PPG (1.7% and 2.9%, respectively) than after DG (0.5% and 0.6%, respectively) (p = 0.036 and p = 0.001) before the conducting of PSW. To minimize bias in the comparative analysis, factors showing differences in complications were identified and compensated for using PSW. However, the occurrence of severe CD IIIa or higher complications did not differ between the DG (12.5%) and PPG (16.0%) (p = 0.574) groups.
The implementation of health screening initiatives has led to an increase in the incidence of cases of EGC, especially in East Asian countries such as Korea and Japan [28,33,34,35,36,37]. This is a positive development, as early treatment has shown promising oncologic outcomes. As a result, surgeons are now placing equal importance on the postoperative outcomes, including quality of life (QOL), of these patients with early detected EGC in addition to their survival.
PPG is known to cause relatively more gastric dysmotility complications, such as delayed gastric emptying, than other gastrectomies [8,15,18,19]. Delayed gastric emptying, also known as gastroparesis, is a detrimental condition of gastric motility that is defined by a slow emptying of solids without a mechanical intestinal obstruction. Although there are numerous clinical contexts in which delayed gastric emptying can occur, the majority of cases are associated with idiopathic, diabetic, and postsurgical etiologies due to vagus nerve injury [38]. Because vagal nerve injury occurs following abdominal surgery, such as PPG, certain gastroparesis patients experience delayed stomach emptying. Recently, function-preserving gastrectomies that improve quality of life have become relatively popular in an effort to avoid postoperative dumping syndrome and duodenal juice reflux. One such procedure is PPG, which has been used to treat early gastric cancer in the middle third of the stomach [39]. In the early postoperative phase, however, gastric stasis was noted in patients who undergo PPG. It has been accepted that appropriate pyloric function requires both preservation of the right gastric artery and the pyloric branch of the vagus nerve. The vagal supply and the right gastric artery should be preserved during the delicate dissection of the perigastric and suprapyloric lymph nodes [39]. Therefore, a relatively small number of surgeons have performed PPGs. The reasons why surgeons hesitate to choose PPG instead of DG include the limitations in accurate staging before surgery, the technical difficulties encountered in sufficient removal of lymph nodes while preserving the nerves and blood vessels around the pylorus, and the concerns that there may be relatively inferior long-term oncological outcomes after PPG compared to DG, even though the postoperative survival rates have been reported to be similar between PPG and DG [9]. Improving gastric motility after PPG could enhance the efficacy of PPG and promote its use. Consequently, it is difficult to accurately compare surgical data between patients who underwent DG and the small number of patients who underwent PPG. Among the function-preserving gastrectomies, PPG in particular should be performed only if cT1N0M0 is diagnosed before surgery [40,41]. In addition, surgery can be performed when the tumor size is small and the tumor is appropriately located in the middle third of the stomach [8]. This can also be observed in this study, which showed that the tumor size was significantly smaller in the PPG group than in the DG group.
The advantages of a minimally invasive approach also apply to PPG. Compared to the open approach, laparoscopic PPG provides some benefits, such as reduced operative wound pain, less blood loss during surgery, and early recovery [10,23,42,43,44]. Therefore, in most cases, the laparoscopic approach for PPG is commonly performed instead of open surgery. In the present study, minimally invasive gastrectomy was performed more often than open gastrectomy (p < 0.001) (Table 1). More specifically, totally laparoscopic (intra-corporeal anastomosis) PPG (47.3%) was performed the most often, laparoscopy-assisted (extra-corporeal anastomosis) PPG and robotic PPG were performed at similar frequencies (25.7%), and open PPG (1.2%) was performed very rarely. During totally laparoscopic PPG, intracorporeal gastro-gastrostomy can be performed in many ways. Compared to extracorporeal reconstruction, intracorporeal anastomosis is reported to be safer and more feasible for minimally invasive PPG [45,46].
In addition, we compared severe complications (CD IIIa or higher) only in the minimally invasive surgery group. Severe complications were found to have occurred in more patients after PPG (6.3%) than after DG (3.3%) before PSW (p = 0.017). However, there was no difference found between the PPG (5.2%) and DG group (6.2%) after PSW (p = 0.709). Some of the common and serious surgical complications after gastrectomy are anastomosis leakage and stricture. In the present study, before conducting PSW, the incidence rates of severe complications (CD IIIa or higher) were significantly different between the DG and PPG groups. Both anastomosis leakage and stricture were more common after PPG than after DG (p = 0.036 and 0.001) (Table 2). The incidence of anastomosis leakage after PPG (1.7%) might be attributed to the suturing of a wider area in this procedure than in B-I anastomosis. On the other hand, the advantage of PPG is that duodenal stump leakage, another serious complication, does not occur. Even before and after conducting PSW, except for anastomosis leakage and stricture, the occurrence of postoperative bleeding, intra-abdominal injury to another organ, wound problems, and other organ diseases were similar between the DG and PPG groups.
There are several limitations in this study. First, because this study was based on survey data, there were some missing values. Second, PPG is not a popular surgical method for gastric cancer; therefore, the number of patients who underwent PPG (n = 241) was notably smaller than the number of patients who underwent DG (n = 9183). In addition, 91% of PPG operations were performed in three hospitals. The surgeons with a large amount of experience, like those in South Korea, preferred DG to PPG. This difference might be self-explicative when it comes to the choice of the best method for the operative treatment of gastric cancers in a clinical setting. Third, although delayed gastric emptying is known to occur more frequently after PPG, as many cohort studies have already reported, there were no data on delayed gastric emptying in the present study [9,12,13,16,17,18,47,48]. Nevertheless, to the best of our knowledge, this is the first study to compare postoperative complications between conventional DG and PPG using large-scale nationwide survey data with PSW.

5. Conclusions

In conclusion, based on the results of a nationwide survey data analysis in which PSW was applied to minimize bias, the occurrence of all grades or severe complications after PPG was similar to that after DG among gastric cancer patients. Additionally, the incidence rates of postoperative anastomotic leakage and stricture, which are thought to be serious complications, were similar after the two operations.

Author Contributions

Conceptualization, S.-H.J., M.P. and J.-S.M.; methodology, S.-H.J., R.B.K., K.W.S. and J.-S.M.; software, R.B.K.; data curation, S.-H.J., K.W.S. and Information Committee of the Korean Gastric Cancer Association; writing—original draft preparation, S.-H.J. and M.P.; writing—review and editing, J.-S.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

These studies were designed and conducted in accordance with the principles of the Helsinki Declaration (as revised in 2013). The studies were approved by the Institutional Review Board (GNUCH 2023-09-024) (2023-10-12). Consent was obtained from all patients prior to the experiment.

Informed Consent Statement

Patient consent was waived as there is no information that can identify the patients.

Data Availability Statement

Data are contained within the article.

Acknowledgments

This research was supported by the nationwide survey project of the Information Committee funded by the Korean Gastric Cancer Association (number: KGCA2022ICx).

Conflicts of Interest

No potential conflicts of interest relevant to this article were reported.

References

  1. Kim, S.M.; Cho, J.; Kang, D.; Oh, S.J.; Kim, A.R.; Sohn, T.S.; Noh, J.H.; Kim, S. A Randomized Controlled Trial of Vagus Nerve-preserving Distal Gastrectomy versus Conventional Distal Gastrectomy for Postoperative Quality of Life in Early Stage Gastric Cancer Patients. Ann. Surg. 2016, 263, 1079–1084. [Google Scholar] [CrossRef]
  2. Ichikawa, D.; Komatsu, S.; Kubota, T.; Okamoto, K.; Shiozaki, A.; Fujiwara, H.; Otsuji, E. Long-term outcomes of patients who underwent limited proximal gastrectomy. Gastric Cancer 2014, 17, 141–145. [Google Scholar] [CrossRef]
  3. Hiki, N.; Nunobe, S.; Kubota, T.; Jiang, X. Function-preserving gastrectomy for early gastric cancer. Ann. Surg. Oncol. 2013, 20, 2683–2692. [Google Scholar] [CrossRef]
  4. Nishikawa, K.; Kawahara, H.; Yumiba, T.; Nishida, T.; Inoue, Y.; Ito, T.; Matsuda, H. Functional characteristics of the pylorus in patients undergoing pylorus-preserving gastrectomy for early gastric cancer. Surgery 2002, 131, 613–624. [Google Scholar] [CrossRef]
  5. Maki, T.; Shiratori, T.; Hatafuku, T.; Sugawara, K. Pylorus-preserving gastrectomy as an improved operation for gastric ulcer. Surgery 1967, 61, 838–845. [Google Scholar]
  6. An, J.Y.; Min, J.S.; Hur, H.; Lee, Y.J.; Cho, G.S.; Park, Y.K.; Jung, M.R.; Park, J.H.; Hyung, W.J.; Jeong, S.H.; et al. Laparoscopic sentinel node navigation surgery versus laparoscopic gastrectomy with lymph node dissection for early gastric cancer: Short-term outcomes of a multicentre randomized controlled trial (SENORITA). Br. J. Surg. 2020, 107, 1429–1439. [Google Scholar] [CrossRef]
  7. Kim, Y.W.; Min, J.S.; Yoon, H.M.; An, J.Y.; Eom, B.W.; Hur, H.; Lee, Y.J.; Cho, G.S.; Park, Y.K.; Jung, M.R.; et al. Laparoscopic Sentinel Node Navigation Surgery for Stomach Preservation in Patients with Early Gastric Cancer: A Randomized Clinical Trial. J. Clin. Oncol. 2022, 40, 2342–2351. [Google Scholar] [CrossRef]
  8. Oh, S.Y.; Lee, H.J.; Yang, H.K. Pylorus-Preserving Gastrectomy for Gastric Cancer. J. Gastric Cancer 2016, 16, 63–71. [Google Scholar] [CrossRef]
  9. Suh, Y.S.; Han, D.S.; Kong, S.H.; Kwon, S.; Shin, C.I.; Kim, W.H.; Kim, H.H.; Lee, H.J.; Yang, H.K. Laparoscopy-assisted pylorus-preserving gastrectomy is better than laparoscopy-assisted distal gastrectomy for middle-third early gastric cancer. Ann. Surg. 2014, 259, 485–493. [Google Scholar] [CrossRef]
  10. Nunobe, S.; Sasako, M.; Saka, M.; Fukagawa, T.; Katai, H.; Sano, T. Symptom evaluation of long-term postoperative outcomes after pylorus-preserving gastrectomy for early gastric cancer. Gastric Cancer 2007, 10, 167–172. [Google Scholar] [CrossRef]
  11. Mao, X.; Xu, X.; Zhu, H.; Ji, C.; Lu, X.; Wang, B. A comparison between pylorus-preserving and distal gastrectomy in surgical safety and functional benefit with gastric cancer: A systematic review and meta-analysis. World J. Surg. Oncol. 2020, 18, 160. [Google Scholar] [CrossRef]
  12. Eom, B.W.; Park, B.; Yoon, H.M.; Ryu, K.W.; Kim, Y.W. Laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer: A retrospective study of long-term functional outcomes and quality of life. World J. Gastroenterol. 2019, 25, 5494–5504. [Google Scholar] [CrossRef]
  13. Song, P.; Lu, M.; Pu, F.; Zhang, D.; Wang, B.; Zhao, Q. Meta-analysis of pylorus-preserving gastrectomy for middle-third early gastric cancer. J. Laparoendosc. Adv. Surg. Tech. A 2014, 24, 718–727. [Google Scholar] [CrossRef]
  14. Mine, S.; Sano, T.; Tsutsumi, K.; Murakami, Y.; Ehara, K.; Saka, M.; Hara, K.; Fukagawa, T.; Udagawa, H.; Katai, H. Large-scale investigation into dumping syndrome after gastrectomy for gastric cancer. J. Am. Coll. Surg. 2010, 211, 628–636. [Google Scholar] [CrossRef]
  15. Park, D.J.; Lee, H.J.; Jung, H.C.; Kim, W.H.; Lee, K.U.; Yang, H.K. Clinical outcome of pylorus-preserving gastrectomy in gastric cancer in comparison with conventional distal gastrectomy with Billroth I anastomosis. World J. Surg. 2008, 32, 1029–1036. [Google Scholar] [CrossRef]
  16. Shibata, C.; Shiiba, K.I.; Funayama, Y.; Ishii, S.; Fukushima, K.; Mizoi, T.; Koyama, K.; Miura, K.; Matsuno, S.; Naito, H.; et al. Outcomes after pylorus-preserving gastrectomy for early gastric cancer: A prospective multicenter trial. World J. Surg. 2004, 28, 857–861. [Google Scholar] [CrossRef]
  17. Isozaki, H.; Okajima, K.; Momura, E.; Ichinona, T.; Fujii, K.; Izumi, N.; Takeda, Y. Postoperative evaluation of pylorus-preserving gastrectomy for early gastric cancer. Br. J. Surg. 1996, 83, 266–269. [Google Scholar]
  18. Otake, R.; Kumagai, K.; Ohashi, M.; Makuuchi, R.; Ida, S.; Sano, T.; Nunobe, S. Reflux Esophagitis After Laparoscopic Pylorus-Preserving Gastrectomy for Gastric Cancer. Ann. Surg. Oncol. 2023, 30, 2294–2303. [Google Scholar] [CrossRef]
  19. Takahashi, R.; Ohashi, M.; Hiki, N.; Makuuchi, R.; Ida, S.; Kumagai, K.; Sano, T.; Nunobe, S. Risk factors and prognosis of gastric stasis, a crucial problem after laparoscopic pylorus-preserving gastrectomy for early middle-third gastric cancer. Gastric Cancer 2020, 23, 707–715. [Google Scholar] [CrossRef]
  20. Kiyokawa, T.; Hiki, N.; Nunobe, S.; Honda, M.; Ohashi, M.; Sano, T. Preserving infrapyloric vein reduces postoperative gastric stasis after laparoscopic pylorus-preserving gastrectomy. Langenbecks Arch. Surg. 2017, 402, 49–56. [Google Scholar] [CrossRef]
  21. Shibata, C.; Saijo, F.; Kakyo, M.; Kinouchi, M.; Tanaka, N.; Sasaki, I.; Aikou, T. Current status of pylorus-preserving gastrectomy for the treatment of gastric cancer: A questionnaire survey and review of literatures. World J. Surg. 2012, 36, 858–863. [Google Scholar] [CrossRef]
  22. Kong, S.H.; Kim, J.W.; Lee, H.J.; Kim, W.H.; Lee, K.U.; Yang, H.K. The safety of the dissection of lymph node stations 5 and 6 in pylorus-preserving gastrectomy. Ann. Surg. Oncol. 2009, 16, 3252–3258. [Google Scholar] [CrossRef]
  23. Hiki, N.; Shimoyama, S.; Yamaguchi, H.; Kubota, K.; Kaminishi, M. Laparoscopy-assisted pylorus-preserving gastrectomy with quality controlled lymph node dissection in gastric cancer operation. J. Am. Coll. Surg. 2006, 203, 162–169. [Google Scholar] [CrossRef]
  24. Sawai, K.; Takahashi, T.; Fujioka, T.; Minato, H.; Taniguchi, H.; Yamaguchi, T. Pylorus-preserving gastrectomy with radical lymph node dissection based on anatomical variations of the infrapyloric artery. Am. J. Surg. 1995, 170, 285–288. [Google Scholar] [CrossRef]
  25. Jeong, S.H.; Seo, K.W.; Min, J.S. Intraoperative Tumor Localization of Early Gastric Cancers. J. Gastric Cancer 2021, 21, 4–15. [Google Scholar] [CrossRef]
  26. Lee, H.J.; Alzahrani, K.M.; Kim, S.R.; Park, J.H.; Suh, Y.S.; Park, D.J.; Lee, H.J.; Yang, H.K.; Kong, S.H. Comparison between laparoscopic pylorus-preserving gastrectomy and laparoscopic distal gastrectomy for overweight patients with early gastric cancer. Ann. Surg. Treat. Res. 2023, 104, 18–26. [Google Scholar] [CrossRef]
  27. Imada, T.; Rino, Y.; Takahashi, M.; Suzuki, M.; Tanaka, J.; Shiozawa, M.; Kabara, K.; Hatori, S.; Ito, H.; Yamamoto, Y.; et al. Postoperative functional evaluation of pylorus-preserving gastrectomy for early gastric cancer compared with conventional distal gastrectomy. Surgery 1998, 123, 165–170. [Google Scholar] [CrossRef]
  28. Information Committee of the Korean Gastric Cancer Association. Korean Gastric Cancer Association-Led Nationwide Survey on Surgically Treated Gastric Cancers in 2019. J. Gastric Cancer 2021, 21, 221–235. [Google Scholar] [CrossRef]
  29. Information Committee of the Korean Gastric Cancer Association. Korean Gastric Cancer Association Nationwide Survey on Gastric Cancer in 2014. J. Gastric Cancer 2016, 16, 131–140. [Google Scholar] [CrossRef]
  30. TNM Classification of Malignant Tumours, 8th ed.; Wiley-Blackwell: Hoboken, NJ, USA, 2016.
  31. WHO Classification of Tumours of the Digestive System, 4th ed.; WHO Press: Geneva, Switzerland, 2010; Volume 3, pp. 48–58.
  32. Dindo, D.; Demartines, N.; Clavien, P.A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004, 240, 205–213. [Google Scholar] [CrossRef]
  33. Park, S.H.; Kang, M.J.; Yun, E.H.; Jung, K.W. Epidemiology of Gastric Cancer in Korea: Trends in Incidence and Survival Based on Korea Central Cancer Registry Data (1999–2019). J. Gastric Cancer 2022, 22, 160–168. [Google Scholar] [CrossRef]
  34. Hong, S.; Won, Y.J.; Lee, J.J.; Jung, K.W.; Kong, H.J.; Im, J.S.; Seo, H.G. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018. Cancer Res. Treat. 2021, 53, 301–315. [Google Scholar] [CrossRef]
  35. Katai, H.; Ishikawa, T.; Akazawa, K.; Isobe, Y.; Miyashiro, I.; Oda, I.; Tsujitani, S.; Ono, H.; Tanabe, S.; Fukagawa, T.; et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: A retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer 2018, 21, 144–154. [Google Scholar] [CrossRef]
  36. Kim, Y.G.; Kong, S.H.; Oh, S.Y.; Lee, K.G.; Suh, Y.S.; Yang, J.Y.; Choi, J.; Kim, S.G.; Kim, J.S.; Kim, W.H.; et al. Effects of screening on gastric cancer management: Comparative analysis of the results in 2006 and in 2011. J. Gastric Cancer 2014, 14, 129–134. [Google Scholar] [CrossRef]
  37. Tsugane, S.; Sasazuki, S. Diet and the risk of gastric cancer: Review of epidemiological evidence. Gastric Cancer 2007, 10, 75–83. [Google Scholar] [CrossRef]
  38. Friedenberg, F.K.; Parkman, H.P. Delayed gastric emptying: Whom to test, how to test, and what to do. Curr. Treat. Options Gastroenterol. 2006, 9, 295–304. [Google Scholar] [CrossRef]
  39. Nakabayashi, T.; Mochiki, E.; Garcia, M.; Haga, N.; Suzuki, T.; Asao, T.; Kuwano, H. Pyloric motility after pylorus-preserving gastrectomy with or without the pyloric branch of the vagus nerve. World J. Surg. 2002, 26, 577–583. [Google Scholar] [CrossRef]
  40. Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: An Evidence-based, Multi-disciplinary Approach. J. Gastric Cancer 2019, 19, 1–48. [Google Scholar] [CrossRef]
  41. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017, 20, 1–19. [Google Scholar] [CrossRef]
  42. Kumagai, K.; Hiki, N.; Nunobe, S.; Sekikawa, S.; Chiba, T.; Kiyokawa, T.; Jiang, X.; Tanimura, S.; Sano, T.; Yamaguchi, T. Totally laparoscopic pylorus-preserving gastrectomy for early gastric cancer in the middle stomach: Technical report and surgical outcomes. Gastric Cancer 2015, 18, 183–187. [Google Scholar] [CrossRef]
  43. Tanaka, N.; Katai, H.; Saka, M.; Morita, S.; Fukagawa, T. Laparoscopy-assisted pylorus-preserving gastrectomy: A matched case-control study. Surg. Endosc. 2011, 25, 114–118. [Google Scholar] [CrossRef] [PubMed]
  44. Hiki, N.; Kaminishi, M. Pylorus-preserving gastrectomy in gastric cancer surgery-open and laparoscopic approaches. Langenbecks Arch. Surg. 2005, 390, 442–447. [Google Scholar] [CrossRef] [PubMed]
  45. Akiyama, Y.; Sasaki, A.; Iwaya, T.; Fujisawa, R.; Sasaki, N.; Nikai, H.; Endo, F.; Baba, S.; Hasegawa, Y.; Kimura, T.; et al. Feasibility of totally laparoscopic pylorus-preserving gastrectomy with intracorporeal gastro-gastrostomy for early gastric cancer: A retrospective cohort study. World J. Surg. Oncol. 2020, 18, 170. [Google Scholar] [CrossRef] [PubMed]
  46. Park, J.H.; Kong, S.H.; Choi, J.H.; Park, S.H.; Suh, Y.S.; Park, D.J.; Lee, H.J.; Yang, H.K. Proximal Anterior-Antrum Posterior (PAAP) Overlapping Anastomosis in Minimally Invasive Pylorus-Preserving Gastrectomy for Early Gastric Cancer Located in the High Body and Posterior Wall of the Stomach. J. Gastric Cancer 2020, 20, 277–289. [Google Scholar] [CrossRef] [PubMed]
  47. Xiao, X.M.; Gaol, C.; Yin, W.; Yu, W.H.; Qi, F.; Liu, T. Pylorus-Preserving versus Distal Subtotal Gastrectomy for Surgical Treatment of Early Gastric Cancer: A Meta-Analysis. Hepatogastroenterology 2014, 61, 870–879. [Google Scholar]
  48. Jiang, X.; Hiki, N.; Nunobe, S.; Fukunaga, T.; Kumagai, K.; Nohara, K.; Sano, T.; Yamaguchi, T. Postoperative outcomes and complications after laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer. Ann. Surg. 2011, 253, 928–933. [Google Scholar] [CrossRef]
Cancers 16 02203 g001
Figure 1. Flow chart of study selection.
Figure 1. Flow chart of study selection.
Cancers 16 02203 g001
Cancers 16 02203 g002
Figure 2. Absolute standardized differences before and after propensity score weighting comparing covariate values between the digital gastrectomy (DG) and pylorus-preserving gastrectomy (PPG) groups. TLG, totally laparoscopic.
Figure 2. Absolute standardized differences before and after propensity score weighting comparing covariate values between the digital gastrectomy (DG) and pylorus-preserving gastrectomy (PPG) groups. TLG, totally laparoscopic.
Cancers 16 02203 g002
Table 1. Comparison of patients’ features before and after propensity score weighting.
Table 1. Comparison of patients’ features before and after propensity score weighting.
Factors Before PSM
DG (n = 9183)		Before PSM
PPG (n = 241)		p Value (95% CI)Factors After PSM
DG (n = 239.7)		After PSM
PPG (n = 241)		p Value
Hospital number6414
Age (years) 62.9 ± 11.860.0 ± 11.6<0.001 (1.34~4.37)Age (years) 60.2 ± 11.660.1 ±11.60.842
SexM5918 (64.4%)112 (46.5%)<0.001SexM115.9112.00.751
F3265 (35.6%)129 (53.5%) F123.8129.0
BMI (kg/m2) 24.1 ± 3.323.6 ± 2.90.013 (0.10~0.859)BMI (kg/m2) 24.2 ± 3.323.7 ± 2.90.006
Tumor size (cm) 3.3 ± 2.22.2 ± 1.3<0.001 (0.83~1.19)Tumor size (cm) 2.9 ± 1.72.4 ±1.4<0.001
TNM stageI6826 (74.3%)227 (94.2%)<0.001TNM stageI225.4227.00.999
II1265 (13.8%)10 (4.1%) II10.210.0
III1092 (11.9%)4 (1.7%) III4.14.0
Existence of comorbidity 5469 (59.5%)90 (37.3%)<0.001Existence of Comorbidity 18.118.00.999
ASA score12126 (23.7%)103 (42.7%)<0.001ASA score189.490.0
25424 (60.5%)113 (46.9%) 2132.2133.0
31378 (15.4%)24 (10.0%) 3106.2103.00.955
432 (0.4%)1 (0.4%) 4108.9113.0
57 (0.1%)0 524.124.0
Hospital stay (days) 8.6 ± 6.78.3 ±5.50.61Hospital stay (days) 8.6 ± 7.18.4 ± 5.60.560
Approach
methods		Totally laparoscopic gastrectomy5990 (65.2%)114 (47.3%)<0.001Approach methodsTotally laparoscopic gastrectomy115.8114.00.866
Laparoscopy-assisted gastrectomy726 (7.9%)62 (25.7%) Laparoscopy-assisted gastrectomy53.962.0
Open gastrectomy1863 (20.3%)3 (1.2%) Open gastrectomy3.03.0
Robotic gastrectomy604 (6.6%)62 (25.7%) Robotic gastrectomy67.162.0
Number of harvested lymph nodes 38.8 ± 16.140.7 ± 16.10.07Number of harvested lymph nodes 38.5 ± 15.040.7 ± 16.10.039
Clavien–Dindo classification08063 (87.8%)210 (87.1%)0.053Clavien–Dindo classification0213.1210.00.960
I198 (2.2%)4(1.7%) I5.04.0
II576 (6.3%)11 (4.6%) II9.111.0
IIIa173 (1.9%)12 (5.0%) IIIa9.112.0
IIIb106 (1.2%)2 (0.8%) IIIb2.02.0
IVa49 (0.5%)2 (0.8%) IVa1.22.0
IVb3 (0.0%)0 IVb0.00.0
V15 (0.2%)0 V0.10.0
Severe morbidity rate (Clavien–Dindo ≥ IIIa)346/9183 (3.8%)16/241 (6.6%)0.039 Severe morbidity rate (Clavien–Dindo ≥ IIIa)12.516.00.574
Severe morbidity rate in minimal invasive surgery group (TLG + LAG + RAG)239/7320 (3.3%)15/238 (6.3%)0.017 Severe morbidity rate in minimal invasive surgery group (TLG + LAG + RAG)12.315.00.709
Mortality (Clavien–Dindo V)48/9069 (0.5%)0/241 (0%)0.527 Mortality (Clavien–Dindo V)0.31.00.999
DG, distal gastrectomy; PPG, pylorus-preserving gastrectomy; PSW, propensity score weight; CI, confidence interval; BMI, body mass index; ASA, American Society of Anesthesiologists; TLG, totally laparoscopic gastrectomy; LAG, laparoscopy-assisted gastrectomy; RAG, robot-assisted gastrectomy. Severe morbidity means Clavien–Dindo classification IIIa or higher. The difference between continuous variables and their means was found using ANOVA testing and post hoc analysis. The difference of categorical variables in their frequency was implemented using chi-square analysis.
Table 2. Comparison of severe postoperative complications (CD IIIa or higher) between the DG and PPG groups after propensity score weighting.
Table 2. Comparison of severe postoperative complications (CD IIIa or higher) between the DG and PPG groups after propensity score weighting.
Complication
(Total n = 9424)		Before PSW
DG (n = 9183)		Before PSW
PPG (n = 241)		p ValueAfter PSW
DG (n = 239.7)		After PSW
PPG (n = 241)		p Value
Anastomosis leakage45 (0.5%)4 (1.7%)0.0360.44.00.123
Anastomosis stricture52 (0.6%)7 (2.9%)0.0016.27.00.999
Duodenal stump leakage43 (0.5%)0 (0%)0.6291.30.00.498
Intra-abdominal bleeding43 (0.5%)1 (0.4%)1.0001.11.00.999
Intraluminal bleeding32 (0.3%)1 (0.4%)0.5750.71.00.999
Pancreatic fistula17 (0.2%)1 (0.4%)0.3730.31.00.999
Intra-abdominal abscess45 (0.5%)1 (0.4%)1.0000.61.00.999
Fluid collection127 (1.4%)1 (0.4%)0.3865.71.00.068
Wound problem101 (1.1%)2 (0.8%)1.0000.62.00.999
Mechanical ileus103 (1.1%)0 (0%)0.1170.90.00.499
Pneumonia123 (1.3%)4 (1.7%)0.5691.14.00.372
CVA7 (0.1%)0 (0%)1.0000.10.00.999
Heart problem23 (0.3%)0 (0%)1.0000.40.00.999
Others359 (3.9%)9 (3.7%)1.0007.29.00.800
DG, distal gastrectomy, PPG, pylorus-preserving gastrectomy, PSW, propensity score weight, CVA, cerebrovascular accident, difference of categorical variables in their frequency was implemented using chi-square analysis.
Table 3. Multivariate logistic regression for severe complications (CD IIIa or higher) between the DG and PPG groups after propensity score weighting.
Table 3. Multivariate logistic regression for severe complications (CD IIIa or higher) between the DG and PPG groups after propensity score weighting.
Covariates OR (95% CI)p Value
GroupDG–
PPG1.25 (1.05–1.50)0.012
Age 1.00 (0.99–1.01)0.431
SexMale
Female0.39 (0.32–0.46)<0.001
StageI–
II0.39 (0.20–0.68)0.002
III0.88 (0.43–1.63)0.716
ComorbidityNo
Yes0.91 (0.60–1.42)0.653
Unknown1.72 (1.16–2.66)0.010
ASA score1–
21.49 (1.20–1.85)<0.001
33.12 (2.30–4.23)<0.001
40.30 (∞–4.14)0.589
50.35 (∞–∞)1.000
Unknown0.36 (∞–∞)0.999
ApproachTotally laparoscopic–
Laparoscopy-assisted1.54 (1.25–1.89)<0.001
Open gastrectomy3.08 (1.85–4.96)<0.001
Robotic gastrectomy0.64 (0.49–0.82)0.001
DG, distal gastrectomy, PPG, pylorus-preserving gastrectomy, CI, confidence interval, BMI, body mass index, ASA, American Society of Anesthesiologists.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jeong, S.-H.; Park, M.; Seo, K.W.; Kim, R.B.; Min, J.-S.; Information Committee of the Korean Gastric Cancer Association. A Comparative Study of Postoperative Complications Associated with Distal Gastrectomy and Pylorus-Preserving Gastrectomy among Gastric Cancer Patients Based on Nationwide Survey Data and Propensity Score Weighting. Cancers 2024, 16, 2203. https://doi.org/10.3390/cancers16122203

AMA Style

Jeong S-H, Park M, Seo KW, Kim RB, Min J-S, Information Committee of the Korean Gastric Cancer Association. A Comparative Study of Postoperative Complications Associated with Distal Gastrectomy and Pylorus-Preserving Gastrectomy among Gastric Cancer Patients Based on Nationwide Survey Data and Propensity Score Weighting. Cancers. 2024; 16(12):2203. https://doi.org/10.3390/cancers16122203

Chicago/Turabian Style

Jeong, Sang-Ho, Miyeong Park, Kyung Won Seo, Rock Bum Kim, Jae-Seok Min, and Information Committee of the Korean Gastric Cancer Association. 2024. "A Comparative Study of Postoperative Complications Associated with Distal Gastrectomy and Pylorus-Preserving Gastrectomy among Gastric Cancer Patients Based on Nationwide Survey Data and Propensity Score Weighting" Cancers 16, no. 12: 2203. https://doi.org/10.3390/cancers16122203

APA Style

Jeong, S. -H., Park, M., Seo, K. W., Kim, R. B., Min, J. -S., & Information Committee of the Korean Gastric Cancer Association. (2024). A Comparative Study of Postoperative Complications Associated with Distal Gastrectomy and Pylorus-Preserving Gastrectomy among Gastric Cancer Patients Based on Nationwide Survey Data and Propensity Score Weighting. Cancers, 16(12), 2203. https://doi.org/10.3390/cancers16122203

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop